-
Sep 062024The latest research results of Moderna monkeypox virus mRNA vaccine have been...
On August 3, 2022, Moderna announced a new research plan to use mRNA technology for the development of monkeypox vaccines. In addition to mRNA vaccine
-
Sep 052024Roche releases Phase 2 clinical trial data for drugs used to treat multiple s...
On September 5, 2024, Roche released new data from the 48 week open label extension (OLE) study of the Phase 2 clinical trial FENopta. The results sho
-
Aug 212024The EU has accepted the application for regulation of Bristol Myers Squibb CA...
On August 20th, Bristol Myers Squibb announced that the European Medicines Agency (EMA) has completed the validation of its new indication application
-
Aug 212024Chinese made dual antibody ADC authorized to Merck
Sichuan Kelun Pharmaceutical has authorized dual antibody ADC to Merck, and Merck has initiated ten global phase 3 clinical trials of the drug for dif
-
Jul 222024Roche's potential ‘best in class’ small molecule therapy positive clinical re...
On July 18, 2024, Roche announced the positive results of its Phase 1 clinical trial of oral small molecule CT-996 for weight loss. The data showed th
-
Jul 192024Albion Announces Phase III Clinical Data of COVID-19 Mutant (BA. 4/5) mRNA Va...
On July 17, 2024, Med, the flagship medical journal of Cell Press, published the clinical data of Phase III protective power of Albo COVID-19 mutant (
-
Mar 112024Introduction to excipient substances
The general requirements for excipients are stable properties, no compatibility or contraindications with the main drug, no side effects, no impact on
-
Feb 192024What is an excipient
Excipients, in drug formulations, are additives other than the main drug, and can also be referred to as excipients. Such as adhesives, fillers, disin
-
Feb 182024Application of iodomethane
1. Used as a methylation reagent. 2. Previously proposed as a component of fungicides, herbicides, insecticides or nematicides, and fire extinguishers
-
Feb 172024Toxicological data of iodomethane
1. Acute toxicity LD50: 100-200mg/kg (rat oral) LC50: 1300mg/m3 (rat inhalation, 4h) 2. Irritation: Human transdermal: 1g (30min), mild irritation. 3.
-
Feb 162024Molecular structure data of iodomethane
Molar refractive index: 19.65 Molar volume (cm3/mol): 63.8 Isometric volume (90.2K): 145.9 Surface tension (dyne/cm): 27.2 Polarization rate (10-24cm3
-
Feb 152024Physical and chemical properties of iodomethane
Melting point: -64 ℃ Boiling point: 40.3 ℃ Flash point: 7.8 ℃ Density: 2.28g/cm3 LogP: 1.50 Refractive index: 1.528 Appearance: Colorless liquid Solub

